JOINT FILING AGREEMENTJoint Filing Agreement • November 6th, 2019 • Parfield International LTD • Biological products, (no disgnostic substances)
Contract Type FiledNovember 6th, 2019 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Ordinary Shares, $0.0001 par value, of China Biologic Products Holdings, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.